Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Alirocumab on Cardiovascular Events in Individuals With Atherosclerotic Cardiovascular Disease But Without Prior Ischemic Events

NCT07615179 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT07615179
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07615179 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Alirocumab on Cardiovascular Events in Individuals With Atherosclerotic Cardiovascular Disease But Without Prior Ischemic Events
Lead sponsor
Sanofi
Phase
Observational
Overall status
Completed
Start date
February 17, 2025
Completion date
May 30, 2026
Enrollment
4,545 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic cardiovascular disease without prior ischemic events